Geneoscopy

Geneoscopy is a life sciences company dedicated to transforming gastrointestinal health through innovative diagnostic tests. They are passionate about personalized medicine and believe their work can improve the lives of patients suffering from gastrointestinal diseases. Their mission is to empower patients and healthcare providers with safe, effective, and accessible tests that help prevent, detect, and monitor diseases. Their core technology utilizes a stool-derived eukaryotic RNA (seRNA) biomarker platform, which they believe is a more accurate and dynamic approach to diagnosing and monitoring gastrointestinal diseases than traditional methods.

Geneoscopy has focused on developing a noninvasive, at-home colorectal cancer screening test, ColoSense, which recently received FDA approval. The company is also developing tests for diagnosis, treatment selection, and therapy monitoring in other GI disease areas, such as inflammatory bowel disease (IBD). Their goal is to bridge the gap between patients and providers, ultimately leading to earlier diagnosis, better treatment options, and improved patient outcomes.

Geneoscopy's mission is to empower patients and healthcare providers to transform gastrointestinal health through innovative tests that help prevent, detect, and monitor disease. They are passionate about improving personalized medicine, especially in the field of gastrointestinal disease management, and are committed to making screening for colorectal cancer and other GI diseases safe, effective, convenient, and accessible.

Geneoscopy promotes a culture of innovation, collaboration, and commitment to improving gastrointestinal health. Their passionate team of scientists and business professionals work together to develop cutting-edge diagnostic technologies that empower both patients and healthcare providers. They strive for excellence in everything they do, recognizing the impact of their work on individuals' lives.

Geneoscopy prioritizes diversity, equity, and inclusion by actively fostering a culture that values diverse perspectives, backgrounds, and experiences. Their commitment extends to their leadership, workforce, and clinical trial participants, demonstrating a deliberate effort to reflect the diverse demographics of their target patient population.